Story perspectives

Pentagon Orders Annual Testosterone Tests for 30-plus Soldiers, Judges Scrutinize

7/26/2026

36 6

Center

Hegseth Orders Screening

Defense Secretary Pete Hegseth announced on July 15, 2026 that all service members aged 30 and older will undergo yearly testosterone screening.
Medical and urology experts criticized the policy for lacking clinical guidelines, warned of fertility risks, and Judge Ana Reyes tied it to the transgender lawsuit.
Judge Ana Reyes ordered transgender case to compare testosterone program with treatment for trans men.

Left

Hegseth Orders Screening

Defense Secretary Pete Hegseth announced on July 15, 2026 that all service members 30 and older will receive testosterone screenings, with replacement therapy.
Critics say the policy reinforces a masculine combat ideal and creates unequal treatment of cisgender men versus transgender service members.
Judge Ana Reyes demanded Pentagon explain cisgender soldiers, not transgender troops, receive testosterone therapy.
Medical experts warned unnecessary testosterone replacement could harm fertility and cause health issues.

Blindspot

Democratic senators wrote in a letter to the Defense Department saying the initiative could undermine efforts to evaluate women service members solely on performance.
Within this story's sources, this angle appears mainly in Left-leaning coverage and receives less attention in Center-leaning coverage.

History

Historical Context

The phrase “Don’t Ask, Don’t Tell” entered national conversation when the sitcom Roseanne aired a controversial episode on March 1 1994. The episode, promoted by ABC, drew about 30 million viewers and sparked debate over same-sex representation, illustrating a 1990s media trend that later framed public discussion of military gender-based policies in the United States.

1 of 4

Hegseth Orders Screening

Defense Secretary Pete Hegseth announced on July 15, 2026 that all service members aged 30 and older will undergo yearly testosterone screening.
Medical and urology experts criticized the policy for lacking clinical guidelines, warned of fertility risks, and Judge Ana Reyes tied it to the transgender lawsuit.
Judge Ana Reyes ordered transgender case to compare testosterone program with treatment for trans men.

1 / 4